Treatment of Salivary Gland Hypofunction With Neuro- Electrostimulation
Phase 2
- Conditions
- PolypharmacyXerostomiaSjögren's Syndrome
- Registration Number
- NCT01174329
- Lead Sponsor
- Universidad Autonoma de Nuevo Leon
- Brief Summary
The objective of the study is to evaluate with clinical parameters the performance of Saliwell Crown as a neuro-electrostimulator of the submandibular and sublingual salivary glands in hypofunction status due to polypharmacy or Sjögren's Syndrome in patients with symptoms of xerostomia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 14
Inclusion Criteria
- Age range between 18 and 75 years of age
- Clinical symptoms of xerostomia
- Difference in whole salivary flow between resting and stimulating conditions
- Patient ASA type I to III
- Absence of at least one mandibular third molar inferior, but at least partially dentated in the mandible
Exclusion Criteria
- Patients with antimicrobial treatments in the three previous months
- Smokers
- Intake of bisphosphonates
- Limitation of mandibular opening
- Interoclusal distance smaller than 10 millimetres
- Lack of adequate bone availability for implant placement
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method self-reported xerostomia 4 weeks
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie neuro-electrostimulation's effect on submandibular and sublingual glands in xerostomia?
How does Saliwell Crown compare to pilocarpine or cevimeline in treating xerostomia from Sjögren's Syndrome or polypharmacy?
Are there specific biomarkers that predict response to neuro-electrostimulation in salivary gland hypofunction patients?
What adverse events are associated with long-term use of neuro-electrostimulators like Saliwell Crown in Sjögren's Syndrome patients?
What combination therapies show promise with neuro-electrostimulation for managing xerostomia in autoimmune or medication-induced conditions?
Trial Locations
- Locations (1)
C.D. Especialidad de Periodoncia
🇲🇽Monterrey, Nuevo León, Mexico
C.D. Especialidad de Periodoncia🇲🇽Monterrey, Nuevo León, MexicoMaría G Chapa Arizpe, Dr.Contact+52 81 83 46 62 62maiech@hotmail.com